ASTM-E3002 2023
$34.13
E3002-15(2023) Standard Practice for Assessing the Comparative Efficacy of Products Used for the Decontamination of Chemical Warfare Agents (CWAs) on Skin
Published By | Publication Date | Number of Pages |
ASTM | 2023 |
ASTM E3002-15-Reapproved2023
Active Standard: Standard Practice for Assessing the Comparative Efficacy of Products Used for the Decontamination of Chemical Warfare Agents (CWAs) on Skin
ASTM E3002
Scope
1.1 This practice establishes an in-vivo method for assessing the comparative efficacy of products used for the decontamination of chemical warfare agents (CWAs) on the skin.
1.2 This practice provides a quantitative efficacy comparison of different skin decontamination products.
1.3 To minimize the number of animals used, this in-vivo practice should be performed only after rigorous in-vitro studies of the candidate decontaminant, which can show the implied claims including chemical neutralization, decontamination studies on surfaces and appropriate testing such as cytotoxicity.
1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.5 This standard does not purport to address all of the safety concerns, if any, associated with the use of decontamination products or CWAs. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.6 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Keywords
acetylcholinesterase; Chemical Warfare Agents (CWAs); decontamination and neutralization; GA Tabun; GB Sarin; GD Soman; GF Cyclohexyl Sarin; HD Mustard; in-vitro; in-vivo; LD50; nerve agents; neutralization; protective ratio; organophosphate (OP); skin; VX Nerve Agent;
ICS Code
ICS Number Code 11.100.99 (Other standards related to laboratory medicine)
DOI: 10.1520/E3002-15R23